TB Alliance begins Phase I trial of TBA-354

The not-for-profit Global Alliance for TB Drug Development began a U.S. Phase I trial

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE